These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 36726813)

  • 1. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
    Crickx E; Mahévas M; Michel M; Godeau B
    Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How we manage immune thrombocytopenia in the elderly.
    Mahévas M; Michel M; Godeau B
    Br J Haematol; 2016 Jun; 173(6):844-56. PubMed ID: 27062054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of immune thrombocytopenia in elderly patients.
    Lucchini E; Fanin R; Cooper N; Zaja F
    Eur J Intern Med; 2018 Dec; 58():70-76. PubMed ID: 30274902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging treatments for immune thrombocytopenia.
    Dou X; Yang R
    Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary management of primary immune thrombocytopenia in adults.
    Lakshmanan S; Cuker A
    J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand.
    Choi PY; Merriman E; Bennett A; Enjeti AK; Tan CW; Goncalves I; Hsu D; Bird R
    Med J Aust; 2022 Jan; 216(1):43-52. PubMed ID: 34628650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis and therapy of immune thrombocytopenia].
    Giagounidis A
    Dtsch Med Wochenschr; 2024 Aug; 149(15):895-903. PubMed ID: 39013410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of ITP and AIHA in CVID: A systematic literature review].
    Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
    Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches for the diagnosis and management of immune thrombocytopenia.
    Gafter-Gvili A
    Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Thrombocytopenia in Children: Consensus and Controversies.
    Singh G; Bansal D; Wright NAM
    Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F; Ruggeri M
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
    Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
    Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura.
    Basturk A; Sayin S; Erkurt MA; Sarici A; Ekinci O; Kum A; Berber I; Korkmaz S; Dogan A; Ulas T; Kuku I; Eser B; Altuntas F
    Transfus Apher Sci; 2021 Oct; 60(5):103246. PubMed ID: 34419359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
    Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?
    Saldanha A; Colella MP; Villaça PR; Thachil J; Orsi FA
    Thromb Res; 2024 Sep; 241():109109. PubMed ID: 39137700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of pediatric immune thrombocytopenia].
    Mori M
    Rinsho Ketsueki; 2024; 65(9):1209-1215. PubMed ID: 39358279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenia.
    Bussel J; Cooper N; Boccia R; Zaja F; Newland A
    Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of immune thrombocytopenia].
    Červinek L
    Vnitr Lek; 2018; 64(5):526-529. PubMed ID: 30193522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
    Neunert C; Heitink-Polle KMJ; Lambert MP
    Br J Haematol; 2023 Oct; 203(1):17-22. PubMed ID: 37641973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.